The FDA recently approved two RSV vaccines for adults 60 and older, write Drs. Richard Rupp and Megan Berman in their latest Vaccines Smarts column. Those at the highest risk for serious RSV disease, such as those with chronic heart and lung problems, should strongly consider being vaccinated, they write.